These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14603118)

  • 1. Severe immunodeficiencies: bone marrow transplantation or gene therapy?
    Mariani SM
    MedGenMed; 2003 Jun; 5(2):19. PubMed ID: 14603118
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy's out-of-body experience.
    Scott CT; DeFrancesco L
    Nat Biotechnol; 2016 Jun; 34(6):600-7. PubMed ID: 27281416
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency.
    Montiel-Equihua CA; Thrasher AJ; Gaspar HB
    Curr Gene Ther; 2012 Feb; 12(1):57-65. PubMed ID: 22348551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for ADA-SCID: defining the factors for successful outcome.
    Gaspar HB
    Blood; 2012 Nov; 120(18):3628-9. PubMed ID: 23118212
    [No Abstract]   [Full Text] [Related]  

  • 5. Steps toward gene therapy: 1. The initial trials.
    Blaese RM
    Hosp Pract (1995); 1995 Nov; 30(11):33-40. PubMed ID: 8557801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving Gene Therapy in Primary Immunodeficiency.
    Thrasher AJ; Williams DA
    Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.
    Hoogerbrugge PM; Vossen JM; v Beusechem VW; Valerio D
    Hum Gene Ther; 1992 Oct; 3(5):553-8. PubMed ID: 1420454
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of gene therapy for SCID is being confirmed.
    Cavazzana-Calvo M; Fischer A
    Lancet; 2004 Dec 18-31; 364(9452):2155-6. PubMed ID: 15610783
    [No Abstract]   [Full Text] [Related]  

  • 9. A Journey in the Development of Gene Therapy for Inherited Disorders of the Bone Marrow.
    Kohn D; Wilson JM
    Hum Gene Ther Clin Dev; 2015 Dec; 26(4):203-7. PubMed ID: 26684443
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.
    Silver JN; Flotte TR
    Pharmacogenomics; 2008 Jul; 9(7):947-68. PubMed ID: 18597656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of primary T cell immunodeficiencies.
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
    Smogorzewska EM; Weinberg KI; Kohn DB
    Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for severe combined immunodeficiencies and beyond.
    Fischer A; Hacein-Bey-Abina S
    J Exp Med; 2020 Jan; 217(2):. PubMed ID: 31826240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of gene therapy for immunodeficiency: adenosine deaminase deficiency.
    Blaese RM
    Pediatr Res; 1993 Jan; 33(1 Suppl):S49-53; discussion S53-5. PubMed ID: 8433875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation and alternatives for adenosine deaminase deficiency.
    Gaspar HB
    Immunol Allergy Clin North Am; 2010 May; 30(2):221-36. PubMed ID: 20493398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing Authorization.
    Ylä-Herttuala S
    Mol Ther; 2016 Jun; 24(6):1013-1014. PubMed ID: 27324442
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene transfer to hematopoietic cells--the clinical experience.
    Richter J
    Eur J Haematol; 1997 Aug; 59(2):67-75. PubMed ID: 9293853
    [No Abstract]   [Full Text] [Related]  

  • 18. Success for gene therapy: render unto Caesar that which is Caesar's.
    Qiao J; Diaz RM; Vile RG
    Genome Biol; 2004; 5(8):237. PubMed ID: 15287968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for severe combined immunodeficiency: are we there yet?
    Cavazzana-Calvo M; Fischer A
    J Clin Invest; 2007 Jun; 117(6):1456-65. PubMed ID: 17549248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe combined immunodeficiencies (SCID).
    Fischer A
    Clin Exp Immunol; 2000 Nov; 122(2):143-9. PubMed ID: 11091267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.